340B platforms rebuilt for the volumes — and the audits.
Monolithic 340B program-management systems re-architected into cloud-native microservices, with eligibility, duplicate-discount prevention and Medicaid Exclusion File validation automated — compliance strengthened while capacity tripled.
The problem we keep meeting
340B platforms strain in both directions at once: transaction volumes from contract pharmacies, wholesalers and providers keep climbing, while split billing, accumulator management and reconciliation stay manual — and every manual step is an audit finding waiting to happen. A monolithic architecture makes each fix riskier than the last.
What we actually do
Re-architect the monolith
Java microservices on AWS — Amazon ECS, RDS, S3 and Lambda — so capacity scales with the program instead of against it.
Automate eligibility and compliance checks
Eligibility validation across patient, provider and medication data; automated duplicate-discount detection; Medicaid Exclusion File (MEF) validation built in rather than bolted on.
Make it auditable by construction
Centralized dashboards for operational monitoring and compliance tracking, with policy enforcement in the platform — HRSA and HIPAA posture strengthened by the re-platform, not endangered by it.
Partner with the program's own experts
340B is a domain with real regulatory depth. We bring the engineering and build alongside the covered entity's and TPA's own specialists — we don't claim their expertise.
What this has produced
transaction processing capacity after the re-platform
duplicate-discount prevention and MEF validation, replacing manual reconciliation
compliance strengthened through policy enforcement in the platform
All results above are from a delivered 340B re-platform for a pharmacy technology provider — not projections.
Questions buyers actually ask
Can a 340B platform be modernized without a compliance gap during the transition?
That's the core design constraint. The re-platform is incremental — the monolith keeps operating while services move — and compliance automation (duplicate-discount detection, MEF validation, eligibility checks) lands as platform capability with audit trails, so the compliance posture improves during the modernization rather than pausing for it.
What architecture does a modernized 340B platform use?
In our delivered engagement: Java microservices on AWS — Amazon ECS for services, RDS for transactional data, S3 for documents and data exchange, Lambda for event-driven processing. The result handled 3× the transaction volume of the monolith it replaced.
Which parts of 340B operations can actually be automated?
From delivered work: eligibility validation across patient, provider and medication data; duplicate-discount detection; Medicaid Exclusion File validation; and the operational dashboards that make the program auditable day-to-day. Split-billing and accumulator workflows stop depending on spreadsheets and manual reconciliation.
Do you operate 340B programs?
No — and we're deliberate about that line. We build and modernize the platforms; the covered entity, TPA or pharmacy-technology provider operates the program and owns the regulatory judgment. We bring the technology, you bring the domain.
How do we evaluate whether our platform is a candidate?
Bring the actual system and volumes. We assess it free — architecture, capacity ceiling, where the manual compliance risk sits — and for the right fit build a working prototype before any invoice.
Let's prove it — on a problem of yours.
Bring one real problem. We assess it free — and for the right fit, build a working prototype. No invoice until you decide to take it to production.